- Home
- EVCM vs ZLAB Comparison
EVCM vs ZLAB Comparison
Compare EVCM & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVCM | ZLAB |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | EVCM | ZLAB |
|---|---|---|
| Price | $12.04 | $17.97 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 6 |
| Target Price | $11.50 | ★ $57.22 |
| AVG Volume (30 Days) | 394.6K | ★ 989.7K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $718,038,000.00 | $441,629,000.00 |
| Revenue This Year | N/A | $30.20 |
| Revenue Next Year | $5.60 | $34.71 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 22.13 | ★ 24.14 |
| 52 Week Low | $7.66 | $16.82 |
| 52 Week High | $14.41 | $44.34 |
Technical Indicators
Market Signals| Indicator | EVCM | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 60.59 | 31.02 |
| Support Level | $11.57 | $16.82 |
| Resistance Level | $14.41 | $18.67 |
| Average True Range (ATR) | 0.84 | 0.60 |
| MACD | 0.34 | 0.13 |
| Stochastic Oscillator | 58.04 | 33.24 |
Price Performance
Historical ComparisonAbout EVCM EverCommerce Inc.
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.